The EU and AstraZeneca agree on COVID-19 vaccine supply and on ending litigation.

The European Commission says the company made a “firm commitment” to deliver 300 million doses by March next year. The agreement means AstraZeneca will have to provide 135 million doses by the end of this year and 65 million doses in the first quarter of 2022. The European Union and drug maker AstraZeneca have reached a deal to end a legal battle over the slow pace of COVID-19 vaccine deliveries. The European Commission says the company made a “firm commitment” to deliver 300 million doses by March next year. The agreement means AstraZeneca will have to provide 135 million doses by the end of this year and 65 million doses in the first quarter of 2022.

Commissioner for Health and Food Safety Stella Kyriakides said: "Today's settlement agreement guarantees the delivery of the remaining 200 million COVID-19 vaccine doses by AstraZeneca to the EU. While this week we reached the important milestone of 70% full vaccination of the EU's adult population, there are significant differences in vaccination rates between our Member States, and the continued availability of vaccines, including AstraZeneca's, remain crucial. And as the strongest supporter of global vaccine cooperation and solidarity, we will continue helping the rest of the world. Our aim is to share at least 200 million doses of vaccines through COVAX with low and middle-income countries until the end of this year. Vaccine solidarity is and remains our trademark."

https://ec.europa.eu/commission/presscorner/detail/en/ip_21_4561